As advised in the Getting it Right First Time (GIRFT) national report on dermatology, published in August 2021, 56% of trusts reported that they had to wait for commissioner approval before prescribing drugs approved by the National Institute for Health and Care Excellence (NICE), and 12% of trusts said they had been told by clinical commissioning groups that they could not prescribe certain NICE-approved biologics for psoriasis at the time of NHS England\u2019s data questionnaire in 2018/19.<\/p>
During GIRFT\u2019s subsequent deep dives into the 110 trusts with significant dermatology activity, it became apparent that there was ongoing variation in the way trusts adopt NICE guidelines. While some allow clinicians to prescribe drugs as soon as they are NICE approved, others have processes in place which can produce delays of more than a year in some cases.<\/p>
GIRFT is aiming to publish trust- and system-level data for dermatology on the Model Health System in early 2024, enabling dermatology clinicians and managers to monitor their variation in provision of care, services, and treatments for skin disorders. Specific metrics for inflammatory skin disorders, including biologic prescribing for psoriasis and eczema, will be included. The aim is to use this data to inform the dermatology element of GIRFT\u2019s Further Faster programme to help target unwarranted variation in care provision for inflammatory skin disease. The Further Faster programme supports providers to deliver rapid clinical transformation to reduce 52-week waits.<\/p>
There are no plans to introduce specific targets to adopt the NHS England guidance on Referral Optimisation for people with skin conditions. The Outpatient Recovery & Transformation Programme in NHS England will continue to promote the guidance through NHS England regional teams, integrated care boards and directly to provider organisations.<\/p>
In addition, specific engagement events, such as the webinar delivered on 21 November 2023, will continue to reinforce the need for appropriate and timely referral optimisation across skin care pathways. The programme is working closely with GIRFT and the Further Faster teams to ensure that referral optimisation is seen as a valuable tool to effectively manage the skin care pathway. Through this effort to engage the system combined with the publication of consistent guidance and evidence across the whole skin care pathway, it is hoped that variation can be reduced, across pathway implementation.<\/p>
It should be recognised that there may be appropriate clinical reasons for some regional or local variation, so it is important to ensure that all patients who need specialist skincare have equal access. The programme will look to review data over the course of the year to understand the impact and consider relevant next steps.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4044", "label" : {"_value" : "Biography information for Andrew Stephenson"} } , "answeringMemberConstituency" : {"_value" : "Pendle"} , "answeringMemberPrinted" : {"_value" : "Andrew Stephenson"} , "dateOfAnswer" : {"_value" : "2023-12-18", "_datatype" : "dateTime"} , "groupedQuestionUIN" : [{"_value" : "6510"} , {"_value" : "6511"} , {"_value" : "6513"} ], "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2023-12-18T17:11:22.937Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2023-12-12", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Skin Diseases: Drugs"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, with reference to page 85 of the Getting it Right First Time report on Dermatology, published by the NHS in August 2021, how many and what proportion of trusts are required to wait for commissioner approval before prescribing (a) NICE-approved biologics for psoriasis and (b) other NICE-approved drugs.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4397", "label" : {"_value" : "Biography information for Peter Dowd"} } , "tablingMemberConstituency" : {"_value" : "Bootle"} , "tablingMemberPrinted" : [{"_value" : "Peter Dowd"} ], "uin" : "6512"} , {"_about" : "http://data.parliament.uk/resources/1327493", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1327493/answer", "answerText" : {"_value" : "
The Department is working closely with the European Union, to resolve any outstanding issues relating to implementation of the Northern Ireland Protocol, including supply of medicines.<\/p>
We are taking this forward at the Specialised Committee for the Protocol on Ireland/Northern Ireland and through official-level talks.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4362", "label" : {"_value" : "Biography information for Edward Argar"} } , "answeringMemberConstituency" : {"_value" : "Charnwood"} , "answeringMemberPrinted" : {"_value" : "Edward Argar"} , "dateOfAnswer" : {"_value" : "2021-05-27", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2021-05-27T12:18:01.43Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2021-05-24", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Drugs and Medical Equipment: Northern Ireland"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, what discussions he has had with his EU counterparts on access to medicines and equipment to Northern Ireland after the end of the grace period in December 2021.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4827", "label" : {"_value" : "Biography information for Claire Hanna"} } , "tablingMemberConstituency" : {"_value" : "Belfast South"} , "tablingMemberPrinted" : [{"_value" : "Claire Hanna"} ], "uin" : "6512"} , {"_about" : "http://data.parliament.uk/resources/1166654", "AnsweringBody" : [{"_value" : "Department for Work and Pensions"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1166654/answer", "answerText" : {"_value" : "
It is not possible to answer this question. This answer could only be provided by accessing a substantial number of referrals to ascertain how many relate to advances claimed after 18th<\/sup> September 2019. As a result, we estimate providing this information would incur disproportionate costs.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4142", "label" : {"_value" : "Biography information for Guy Opperman"}
}
, "answeringMemberConstituency" : {"_value" : "Hexham"}
, "answeringMemberPrinted" : {"_value" : "Guy Opperman"}
, "dateOfAnswer" : {"_value" : "2019-11-01", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2019-11-01T10:59:45.43Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "29"}
, "answeringDeptShortName" : {"_value" : "Work and Pensions"}
, "answeringDeptSortName" : {"_value" : "Work and Pensions"}
, "date" : {"_value" : "2019-10-28", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Universal Credit: Fraud"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Work and Pensions, what estimate she has made of the number of universal credit claimants who have been referred for fraud relating to advance claims made after 18 September 2019.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4667", "label" : {"_value" : "Biography information for Mike Amesbury"}
}
, "tablingMemberConstituency" : {"_value" : "Weaver Vale"}
, "tablingMemberPrinted" : [{"_value" : "Mike Amesbury"}
], "uin" : "6512"}
, {"_about" : "http://data.parliament.uk/resources/754643", "AnsweringBody" : [{"_value" : "Department for Education"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/754643/answer", "answerText" : {"_value" : " I am sorry, but the Department does not hold the information requested.<\/p> <\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/1562", "label" : {"_value" : "Biography information for Sir Robert Goodwill"}
}
, "answeringMemberConstituency" : {"_value" : "Scarborough and Whitby"}
, "answeringMemberPrinted" : {"_value" : "Mr Robert Goodwill"}
, "dateOfAnswer" : {"_value" : "2017-09-07", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2017-09-07T11:28:53.637Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "60"}
, "answeringDeptShortName" : {"_value" : "Education"}
, "answeringDeptSortName" : {"_value" : "Education"}
, "date" : {"_value" : "2017-07-20", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Children: Care Homes"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Education, how many care homes there were in (a) England and (b) the North West broken down by (i) local authority ownership, (ii) private ownership and (iii) other for each year for which information is available since the publication of the Children's Home Data Pack in 2014.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/458", "label" : {"_value" : "Biography information for Ann Coffey"}
}
, "tablingMemberConstituency" : {"_value" : "Stockport"}
, "tablingMemberPrinted" : [{"_value" : "Ann Coffey"}
], "uin" : "6512"}
, {"_about" : "http://data.parliament.uk/resources/389076", "AnsweringBody" : [{"_value" : "Department for Transport"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/389076/answer", "answerText" : {"_value" : " The Driver and Vehicle Licensing Agency (DVLA) takes the protection and security of its data very seriously. A comprehensive set of safeguards is in place to ensure data is disclosed only to legitimate organisations and where it is lawful and fair to do so.<\/p> <\/p> <\/p> <\/p> To request information from the DVLA, private parking management companies must be a member of an appropriate Accredited Trade Association. The requirement helps to ensure that those requesting DVLA data operate within a code of practice that promotes fair treatment of the motorist and ensures that there is a clear set of standards for operators including an independent appeals process.<\/p> <\/p> <\/p> <\/p> There are currently two Accredited Trade Associations for the parking industry; the British Parking Association and the Independent Parking Committee.<\/p> <\/p> <\/p> <\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/3996", "label" : {"_value" : "Biography information for Andrew Jones"}
}
, "answeringMemberConstituency" : {"_value" : "Harrogate and Knaresborough"}
, "answeringMemberPrinted" : {"_value" : "Andrew Jones"}
, "dateOfAnswer" : {"_value" : "2015-07-16", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2015-07-16T15:55:38.397Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "27"}
, "answeringDeptShortName" : {"_value" : "Transport"}
, "answeringDeptSortName" : {"_value" : "Transport"}
, "date" : {"_value" : "2015-07-10", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Parking"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Transport, what safeguards are in place to ensure that the DVLA only provides its data to car parking companies which are registered by the British Parking Association.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4382", "label" : {"_value" : "Biography information for Daniel Zeichner"}
}
, "tablingMemberConstituency" : {"_value" : "Cambridge"}
, "tablingMemberPrinted" : [{"_value" : "Daniel Zeichner"}
], "uin" : "6512"}
], "itemsPerPage" : 10, "page" : 0, "startIndex" : 1, "totalResults" : 5, "type" : ["http://purl.org/linked-data/api/vocab#ListEndpoint", "http://purl.org/linked-data/api/vocab#Page"]}
}